INS and COVID-19: The evidence was strengthened that male sex, older age, blood glucose level at admission, use of insulin, use of metformin (inversely), lymphocyte count at admission (inversely) and pre-existing comorbidities such as CVD, CKD and COPD are associated with worse COVID-19-related outcomes.